Baseline characteristics of 32 patients
| Data are numbers of patients or mean (SD). | |
| ACE, angiotensin converting enzyme; ARB, angiotensin II receptor blocker; IABP, intra-aortic balloon pump counterpulsation; LAD, left anterior descending artery; PCI, percutaneous coronary intervention. | |
| Age (years) | 66 (11) |
| Men | 24 (75%) |
| Elapsed time from symptom onset to reperfusion (hours) | 3.4 (1.5) |
| Culprit site | |
| Proximal LAD | 14 (44%) |
| Middle LAD | 18 (56%) |
| Killip class ⩾II | 3 (9%) |
| IABP deployment | 3 (9%) |
| Hypertension | 20 (63%) |
| Diabetes mellitus | 11 (34%) |
| Hyperlipidaemia | 18 (56%) |
| Current smoking | 12 (38%) |
| Oral drugs after PCI | |
| ACE inhibitor | 24 (75%) |
| ARB | 3 (9%) |
| β Blocker | 1 (3%) |
| Calcium antagonist | 1 (3%) |
| Nitrate | 1 (3%) |
| Statin | 15 (47%) |
| Ticlopidine | 31 (97%) |
| Aspirin | 19 (59%) |